{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T21:28:11Z","timestamp":1788038891533,"version":"build-2784847793"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014824","name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2019\/005102"],"award-info":[{"award-number":["CRG\/2019\/005102"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmc.2025.118392","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:51:49Z","timestamp":1758588709000},"page":"118392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Natural-product-inspired potent anticancer congeners: chronological advancements, structure-activity relationship (SAR) studies and future perspectives"],"prefix":"10.1016","volume":"131","author":[{"given":"Abdul","family":"Rahaman T A","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Nandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanmoy","family":"Tantra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118392_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112502","article-title":"Anticancer fungal natural products: mechanisms of action and biosynthesis","author":"Yuan","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.05.027","article-title":"Natural products as multidrug resistance modulators in Cancer","author":"Kumar","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107686","article-title":"The strategies and techniques of drug discovery from natural products","author":"Zhang","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmc.2025.118392_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2016.06.003","article-title":"The modification of natural products for medical use","author":"Guo","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2025.118392_bb0025","doi-asserted-by":"crossref","DOI":"10.1021\/acs.chemrev.9b00063","article-title":"Comprehensive structure-activity relationship studies of macrocyclic natural products enabled by their Total syntheses","author":"Itoh","year":"2019","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2025.118392_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113054","article-title":"Targeting Cancer signaling pathways by natural products: exploring promising anti-Cancer agents","author":"Hashem","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2025.118392_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/j.1751-7915.2010.00221.x","article-title":"Natural products for Cancer chemotherapy","author":"Demain","year":"2011","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.bmc.2025.118392_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.04.012","article-title":"Natural products: An upcoming therapeutic approach to Cancer","author":"Dutta","year":"2019","journal-title":"Food Chem Toxicol"},{"issue":"18","key":"10.1016\/j.bmc.2025.118392_bb0045","doi-asserted-by":"crossref","first-page":"8412","DOI":"10.1021\/acs.jmedchem.9b00246","article-title":"Fixing the unfixable: the art of optimizing natural products for human medicine","volume":"62","author":"Y\u00f1igez-Gutierrez","year":"2019","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bmc.2025.118392_bb0050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2025.118392_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202000059","article-title":"Applications of the pharmacophore concept in natural product inspired drug design","author":"Seidel","year":"2020","journal-title":"Molecular Informatics"},{"key":"10.1016\/j.bmc.2025.118392_bb0060","doi-asserted-by":"crossref","DOI":"10.1080\/17460441.2016.1272757","article-title":"The structural modification of natural products for novel drug discovery","author":"Yao","year":"2017","journal-title":"Expert Opin Drug Discov"},{"issue":"6","key":"10.1016\/j.bmc.2025.118392_bb0065","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1021\/acs.chemrev.8b00504","article-title":"Structural simplification of natural products","volume":"119","author":"Wang","year":"2019","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2025.118392_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111664","article-title":"Natural products as important tyrosine kinase inhibitors","author":"Yin","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114748","article-title":"Bisindole natural products: a vital source for the development of new anticancer drugs","author":"Xu","year":"2022","journal-title":"Eur J Med Chem"},{"issue":"9","key":"10.1016\/j.bmc.2025.118392_bb0080","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1002\/ptr.7099","article-title":"Natural products: a Lead for drug discovery and development","volume":"35","author":"Chopra","year":"2021","journal-title":"Phytother Res"},{"issue":"15","key":"10.1016\/j.bmc.2025.118392_bb0085","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1016\/j.bmcl.2010.06.003","article-title":"Anibamine, a natural product CCR5 antagonist, as a novel Lead for the development of anti-prostate Cancer agents","volume":"20","author":"Zhang","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118392_bb0090","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ejmech.2012.07.049","article-title":"Structure activity relationship studies of natural product chemokine receptor CCR5 antagonist Anibamine toward the development of novel anti prostate Cancer agents","volume":"55","author":"Zhang","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0095","first-page":"240","article-title":"Design, Synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of Olaparib and the natural product Alantolactone","author":"Kayumov","year":"2022","journal-title":"Eur J Med Chem"},{"issue":"26","key":"10.1016\/j.bmc.2025.118392_bb0100","doi-asserted-by":"crossref","first-page":"16755","DOI":"10.1021\/acsomega.1c00745","article-title":"Efficient access to the iboga skeleton: optimized procedure to obtain Voacangine from Voacanga Africana root bark. ACS","volume":"6","author":"Gonz\u00e1lez","year":"2021","journal-title":"Omega"},{"issue":"21","key":"10.1016\/j.bmc.2025.118392_bb0105","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.1c01168","article-title":"Development of novel VEGFR2 inhibitors originating from natural product analogues with antiangiogenic impact","volume":"64","author":"Cho","year":"2021","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2025.118392_bb0110","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/molecules21020150","article-title":"Imidazole Alkaloids from the South China Sea Sponge Pericharax Heteroraphis and Their Cytotoxic and Antiviral Activities","volume":"21","author":"Gong","year":"2016","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bmc.2025.118392_bb0115","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.2c01702","article-title":"Bioactivity-Driven Synthesis of the Marine Natural Product Naamidine J and Its Derivatives as Potential Tumor Immunological Agents by Inhibiting Programmed Death-Ligand 1","volume":"66","author":"Fu","year":"2023","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2025.118392_bb0120","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jmb.2003.08.031","article-title":"Structural characterization of the GSK-3\u03b2 active site using selective and non-selective ATP-mimetic inhibitors","volume":"333","author":"Bertrand","year":"2003","journal-title":"J Mol Biol"},{"issue":"7","key":"10.1016\/j.bmc.2025.118392_bb0125","doi-asserted-by":"crossref","DOI":"10.1021\/jm801317h","article-title":"From a natural product Lead to the identification of potent and selective Benzofuran-3-Yl-(Indol-3-Yl)Maleimides as glycogen synthase kinase 3\u03b2inhibitors that suppress proliferation and survival of pancreatic Cancer cells","volume":"52","author":"Gaisina","year":"2009","journal-title":"J Med Chem"},{"issue":"15","key":"10.1016\/j.bmc.2025.118392_bb0130","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1016\/j.bmcl.2009.05.093","article-title":"Antitumor activity of Deoxypodophyllotoxin isolated from Anthriscus Sylvestris: induction of G2\/M cell cycle arrest and caspase-dependent apoptosis","volume":"19","author":"Yong","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118392_bb0135","first-page":"65 (24)","article-title":"Discovery of novel N-heterocyclic-fused Deoxypodophyllotoxin analogues as tubulin polymerization inhibitors targeting the colchicine-binding site for Cancer treatment","author":"Leng","year":"2022","journal-title":"J Med Chem"},{"issue":"15","key":"10.1016\/j.bmc.2025.118392_bb0140","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1016\/j.bmcl.2012.06.003","article-title":"InCl3-catalysed synthesis of 2-aryl Quinazolin-4(3H)-ones and 5-aryl Pyrazolo[4,3-d]Pyrimidin-7(6H)-ones and their evaluation as potential anticancer agents","volume":"22","author":"Mulakayala","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118392_bb0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phytochem.2014.10.020","article-title":"Quinolone and indole alkaloids from the fruits of Euodia Rutaecarpa and their cytotoxicity against two human Cancer cell lines","volume":"109","author":"Zhao","year":"2015","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bmc.2025.118392_bb0150","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ejphar.2019.04.029","article-title":"Bouchardatine suppresses rectal Cancer in mice by disrupting its metabolic pathways via activating the SIRT1-PGC-1\u03b1-UCP2 Axis","volume":"854","author":"Xu","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.1016\/j.bmc.2025.118392_bb0155","doi-asserted-by":"crossref","first-page":"7387","DOI":"10.1021\/acs.jmedchem.3c00085","article-title":"Design and synthesis of Bouchardatine derivatives as a novel AMP-activated protein kinase activator for the treatment of colorectal Cancer","volume":"66","author":"Xu","year":"2023","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2025.118392_bb0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1074-5521(00)00063-6","article-title":"Inhibition of cyclin-dependent kinases, GSK-3\u03b2 and CK1 by Hymenialdisine, a marine sponge constituent","volume":"7","author":"Meijer","year":"2000","journal-title":"Chem Biol"},{"issue":"49","key":"10.1016\/j.bmc.2025.118392_bb0165","doi-asserted-by":"crossref","first-page":"10176","DOI":"10.1016\/j.tet.2012.09.097","article-title":"New bioactive alkaloids from the marine sponge Stylissa Sp","volume":"68","author":"Fouad","year":"2012","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmc.2025.118392_bb0170","first-page":"56","article-title":"Synthesis and evaluation of novel anti-proliferative Pyrroloazepinone and Indoloazepinone oximes derived from the marine natural product Hymenialdisine","author":"White","year":"2012","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2025.118392_bb0175","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejmech.2011.11.011","article-title":"Design, synthesis and biological evaluation of novel glycosylated Diphyllin derivatives as topoisomerase II inhibitors","volume":"47","author":"Shi","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0180","first-page":"243","article-title":"Synthesis and anti-tumor activity of nitrogen-containing derivatives of the natural product Diphyllin","author":"Li","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2022.113107","article-title":"Anti-tumor alkaloids from Peganum Harmala","volume":"197","author":"Zhang","year":"2022","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bmc.2025.118392_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106401","article-title":"Inspired by Bis-\u03b2-Carboline alkaloids: construction and antitumor evaluation of a novel Bis-\u03b2-Carboline scaffold as potent antitumor agents","volume":"133","author":"Liu","year":"2023","journal-title":"Bioorg Chem"},{"issue":"5","key":"10.1016\/j.bmc.2025.118392_bb0195","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/np200037z","article-title":"Triazole and Dihydroimidazole alkaloids from the marine sediment-derived fungus Penicillium Paneum SD-44","volume":"74","author":"Li","year":"2011","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2025.118392_bb0200","first-page":"224","article-title":"Discovery of Penipanoid C-inspired 2-(3,4,5-Trimethoxybenzoyl)Quinazolin-4(3H)-one derivatives as potential anticancer agents by inhibiting cell proliferation and inducing apoptosis in hepatocellular carcinoma cells","author":"Wang","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0205","first-page":"91 (4)","article-title":"Emetine, a small molecule natural product, displays potent anti-gastric Cancer activity via regulation of multiple signaling pathways","author":"Peng","year":"2023","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bmc.2025.118392_bb0210","doi-asserted-by":"crossref","unstructured":"S. Akinboye, E.; D. Rosen, M.; R. Denmeade, S.; Kwabi-Addo, B.; Bakare, O. Design, Synthesis, and evaluation of PH-dependent Hydrolyzable emetine analogues as treatment for prostate Cancer. J Med Chem 2012, 55 (17), 7450\u20137459. doi:https:\/\/doi.org\/10.1021\/jm300426q.","DOI":"10.1021\/jm300426q"},{"issue":"2","key":"10.1016\/j.bmc.2025.118392_bb0215","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/md12020940","article-title":"Antimicrobial Activity of the Marine Alkaloids, Clathrodin and Oroidin, and Their Synthetic Analogues","volume":"12","author":"Zidar","year":"2014","journal-title":"Marine Drugs"},{"issue":"8","key":"10.1016\/j.bmc.2025.118392_bb0220","doi-asserted-by":"crossref","DOI":"10.1039\/C6MD00163G","article-title":"Synthetic analogues of marine alkaloid Clathrodin differently induce phosphatidylserine exposure in Monocytic Cancer cells then in Cancer stem cell lines","volume":"7","author":"Nabergoj","year":"2016","journal-title":"Medchemcomm"},{"issue":"11\u221212","key":"10.1016\/j.bmc.2025.118392_bb0225","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.lfs.2008.07.011","article-title":"Tanshinone IIA, an isolated compound from salvia Miltiorrhiza Bunge, induces apoptosis in HeLa cells through mitotic arrest","volume":"83","author":"Zhou","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.bmc.2025.118392_bb0230","first-page":"61 (3)","article-title":"Structural modification of natural product Tanshinone i leading to discovery of novel nitrogen-enriched derivatives with enhanced anticancer profile and improved drug-like properties","author":"Ding","year":"2018","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.bmc.2025.118392_bb0235","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.2174\/1568026620666200325110444","article-title":"Preclinical and clinical studies on Bryostatins, a class of marine-derived protein kinase C modulators: a Mini-review","volume":"20","author":"Raghuvanshi","year":"2020","journal-title":"Curr Top Med Chem"},{"issue":"6","key":"10.1016\/j.bmc.2025.118392_bb0240","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1081\/CNV-120025095","article-title":"Bryostatin-1: a novel PKC inhibitor in clinical development","volume":"21","author":"Kortmansky","year":"2003","journal-title":"Cancer Investig"},{"issue":"1","key":"10.1016\/j.bmc.2025.118392_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15742-7","article-title":"Synthesis and evaluation of designed PKC modulators for enhanced Cancer immunotherapy","volume":"11","author":"Hardman","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.bmc.2025.118392_bb0250","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.canlet.2010.07.004","article-title":"Targeting apoptosis pathways by natural compounds in Cancer: marine compounds as Lead structures and chemical tools for Cancer therapy","volume":"332","author":"von Schwarzenberg","year":"2013","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.bmc.2025.118392_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07259-x","article-title":"Design and 22-step synthesis of highly potent D-ring modified and linker-equipped analogs of Spongistatin 1","volume":"9","author":"Suen","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2025.118392_bb0260","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbrc.2023.09.044","article-title":"A review on Millepachine and its derivatives as potential multitarget anticancer agents","volume":"681","author":"Rampogu","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2025.118392_bb0265","first-page":"268","article-title":"Design and biological evaluation of dual tubulin\/HDAC inhibitors based on Millepachine for treatment of prostate Cancer","author":"Xie","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"11","key":"10.1016\/j.bmc.2025.118392_bb0270","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.3390\/molecules22111942","article-title":"Silybin, a Major Bioactive Component of Milk Thistle (Silybum Marianum L. Gaernt.)\u2014Chemistry, Bioavailability, and Metabolism","volume":"22","author":"Bijak","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118392_bb0275","first-page":"133","article-title":"Design and discovery of Silybin analogues as Antiproliferative compounds using a ring disjunctive \u2013 based, natural product Lead optimization approach","author":"Manivannan","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0280","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejmech.2018.10.062","article-title":"Natural products hybrids: 3,5,4\u2032-Trimethoxystilbene-5,6,7-Trimethoxyflavone chimeric analogs as potential cytotoxic agents against diverse human Cancer cells","volume":"161","author":"Hassan","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115566","article-title":"Design, synthesis, and evaluation of new anti-inflammatory natural products amide derivatives endowed with anti-blood Cancer activity towards development of potential multifunctional agents against hematological cancers","volume":"258","author":"Hassan","year":"2023","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2025.118392_bb0290","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jpha.2012.12.001","article-title":"A simple method for the isolation and purification of resveratrol from Polygonum Cuspidatum","volume":"3","author":"Wang","year":"2013","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.bmc.2025.118392_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116060","article-title":"Resveratrol-derived inhibitors of the E3 ubiquitin ligase PELI1 inhibit the metastasis of triple-negative breast Cancer","volume":"265","author":"Xu","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"22","key":"10.1016\/j.bmc.2025.118392_bb0300","doi-asserted-by":"crossref","DOI":"10.1021\/jm050528k","article-title":"Synthesis of a resveratrol analogue with high ceramide-mediated Proapoptotic activity on human breast Cancer cells","volume":"48","author":"Minutolo","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116367","article-title":"Discovery of Ganoderic acid a (GAA) PROTACs as MDM2 protein degraders for the treatment of breast Cancer","volume":"270","author":"Li","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"18","key":"10.1016\/j.bmc.2025.118392_bb0310","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.3c00872","article-title":"Discovery of Triazolyl derivatives of Cucurbitacin B targeting IGF2BP1 against non-small cell lung Cancer","volume":"66","author":"Shang","year":"2023","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2025.118392_bb0315","article-title":"Physalins V-IX, 16,24-Cyclo-13,14-Seco Withanolides from Physalis Angulata and their Antiproliferative and anti-inflammatory activities","volume":"7","author":"Sun","year":"2017","journal-title":"Sci Rep"},{"issue":"19","key":"10.1016\/j.bmc.2025.118392_bb0320","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.0c01128","article-title":"Design and SAR of Withangulatin a analogues that act as covalent TrxR inhibitors through the Michael addition reaction showing potential in Cancer treatment","volume":"63","author":"Wang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/ph16020160","article-title":"A pleiotropic anticancer agent from the Indian medicinal plant Withania Somnifera (L.) Dunal","author":"Kumar","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.bmc.2025.118392_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-13664-x","article-title":"Regiospecific Synthesis of Ring A Fused Withaferin A Isoxazoline Analogues: Induction of Premature Senescence by W-2b in Proliferating Cancer Cells","volume":"7","author":"Rasool","year":"2017","journal-title":"Scientific Reports"},{"issue":"17","key":"10.1016\/j.bmc.2025.118392_bb0335","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.1021\/acs.jmedchem.5b00867","article-title":"Discovery of potent 17\u03b2-Hydroxywithanolides for castration-resistant prostate Cancer by high-throughput screening of a natural products library for androgen-induced gene expression inhibitors","volume":"58","author":"Xu","year":"2015","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bmc.2025.118392_bb0340","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1080\/14786419.2020.1805604","article-title":"New triterpenoid Saponin from the stems of Albizia Adianthifolia (Schumach.) W.Wight","volume":"36","author":"Toukea","year":"2022","journal-title":"Nat Prod Res"},{"issue":"19","key":"10.1016\/j.bmc.2025.118392_bb0345","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1021\/acs.jmedchem.9b00644","article-title":"Natural product Albiziabioside a conjugated with pyruvate dehydrogenase kinase inhibitor Dichloroacetate to induce apoptosis-Ferroptosis-M2-TAMs polarization for combined Cancer therapy","volume":"62","author":"Wei","year":"2019","journal-title":"J Med Chem"},{"issue":"17","key":"10.1016\/j.bmc.2025.118392_bb0350","doi-asserted-by":"crossref","DOI":"10.1021\/jm300605m","article-title":"New tricks for an old natural product: discovery of highly potent Evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations","volume":"55","author":"Dong","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0355","first-page":"11 (4)","article-title":"Natural product Evodiamine with borate trigger unit: discovery of potent antitumor agents against Colon Cancer","author":"Li","year":"2020","journal-title":"ACS Med Chem Lett"},{"issue":"16","key":"10.1016\/j.bmc.2025.118392_bb0360","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.5b00910","article-title":"Scaffold diversity inspired by the natural product Evodiamine: discovery of highly potent and multitargeting antitumor agents","volume":"58","author":"Wang","year":"2015","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2025.118392_bb0365","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.9b01626","article-title":"Scaffold hopping of natural product Evodiamine: discovery of a novel antitumor scaffold with excellent potency against Colon Cancer","volume":"63","author":"Wang","year":"2020","journal-title":"J Med Chem"},{"issue":"23","key":"10.1016\/j.bmc.2025.118392_bb0370","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.1c01411","article-title":"Discovery of novel polycyclic heterocyclic derivatives from Evodiamine for the potential treatment of triple-negative breast Cancer","volume":"64","author":"Xu","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0375","first-page":"114","article-title":"Design, Synthesis and bioactivity study of Evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma","author":"Fan","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0380","article-title":"Oridonin: a review of its pharmacology, Pharmacokinetics and Toxicity","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"issue":"21","key":"10.1016\/j.bmc.2025.118392_bb0385","doi-asserted-by":"crossref","first-page":"8814","DOI":"10.1021\/jm401248x","article-title":"Oridonin ring A-based diverse constructions of Enone functionality: identification of novel Dienone analogues effective for highly aggressive breast Cancer by inducing apoptosis","volume":"56","author":"Ding","year":"2013","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.bmc.2025.118392_bb0390","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1021\/acs.jmedchem.7b01514","article-title":"Regio- and stereospecific synthesis of Oridonin D-ring Aziridinated analogues for the treatment of triple-negative breast Cancer via mediated irreversible covalent warheads","volume":"61","author":"Ding","year":"2018","journal-title":"J Med Chem"},{"issue":"15","key":"10.1016\/j.bmc.2025.118392_bb0395","doi-asserted-by":"crossref","first-page":"8157","DOI":"10.1021\/acs.jmedchem.0c00408","article-title":"Identification of a potent Oridonin analogue for treatment of triple-negative breast Cancer","volume":"63","author":"Yao","year":"2020","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2025.118392_bb0400","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/acs.jmedchem.6b01652","article-title":"A novel potent anticancer compound optimized from a natural Oridonin scaffold induces apoptosis and cell cycle arrest through the mitochondrial pathway","volume":"60","author":"Xu","year":"2017","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.bmc.2025.118392_bb0405","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2174\/1871520619666190118121439","article-title":"Synthesis of Oridonin derivatives via Mizoroki-heck reaction and click chemistry for cytotoxic activity","volume":"19","author":"Hou","year":"2019","journal-title":"Anti Cancer Agents Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0410","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejmech.2019.04.005","article-title":"Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted Oridonin analogs: a novel and potent cell cycle arrest and apoptosis inducer through the P53-MDM2 pathway","volume":"173","author":"Shen","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0415","first-page":"9","article-title":"Strategic application of CuAAC click chemistry in the modification of natural products for anticancer activity","author":"Xiao","year":"2023","journal-title":"European Journal of Medicinal Chemistry Reports"},{"issue":"6","key":"10.1016\/j.bmc.2025.118392_bb0420","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41557-019-0261-6","article-title":"Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis","volume":"11","author":"Llabani","year":"2019","journal-title":"Nature Chemistry"},{"issue":"11","key":"10.1016\/j.bmc.2025.118392_bb0425","doi-asserted-by":"crossref","first-page":"8040","DOI":"10.1021\/acs.jmedchem.2c00615","article-title":"Optimization of the natural product Calothrixin a to discover novel dual topoisomerase I and II inhibitors with improved anticancer activity","volume":"65","author":"Yang","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0430","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/slct.202001908","article-title":"Design, Synthesis and evaluations of new 10-Triazolyl-1-Methoxygenipin analogues for their cytotoxicity to Cancer cells","volume":"5","author":"Silalai","year":"2020","journal-title":"ChemistrySelect"},{"issue":"2","key":"10.1016\/j.bmc.2025.118392_bb0435","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1021\/acsmedchemlett.5b00418","article-title":"New colchicine-derived Triazoles and their influence on cytotoxicity and microtubule morphology","volume":"7","author":"Thomopoulou","year":"2016","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"10.1016\/j.bmc.2025.118392_bb0440","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/14756366.2017.1404590","article-title":"Synthesis and characterisation of Celastrol derivatives as potential anticancer agents","volume":"33","author":"Zhang","year":"2018","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0445","first-page":"91","article-title":"Synthesis and biological evaluation of Bergenin-1,2,3-Triazole hybrids as novel class of anti-mitotic agents","author":"Pavan Kumar","year":"2019","journal-title":"Bioorg Chem"},{"issue":"5","key":"10.1016\/j.bmc.2025.118392_bb0450","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1021\/acs.jmedchem.5b01203","article-title":"Discovery of New Monocarbonyl Ligustrazine\u2013Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer","volume":"59","author":"Ai","year":"2016","journal-title":"J Med Chem"},{"issue":"23","key":"10.1016\/j.bmc.2025.118392_bb0455","doi-asserted-by":"crossref","first-page":"10867","DOI":"10.1021\/acs.jmedchem.9b01405","article-title":"Farnesyl pyrophosphate synthase as a target for drug development: discovery of natural-product-derived inhibitors and their activity in pancreatic Cancer cells","volume":"62","author":"Han","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/md12126142","article-title":"Synthetic approaches to the Lamellarins - a comprehensive review","author":"Imbri","year":"2014","journal-title":"Marine Drugs"},{"key":"10.1016\/j.bmc.2025.118392_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113226","article-title":"Design, synthesis and structure-activity relationship studies of glycosylated derivatives of marine natural product Lamellarin D","volume":"214","author":"Zheng","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2025.118392_bb0470","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1021\/acs.jmedchem.3c02107","article-title":"Discovery of 5-Hydroxy-1,4-naphthoquinone (Juglone) derivatives as dual effective agents targeting platelet-Cancer interplay through protein disulfide isomerase inhibition","volume":"67","author":"Juang","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114008","article-title":"Natural inspired Ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors","volume":"228","author":"Elimam","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0480","first-page":"46","article-title":"Harmine-inspired design and synthesis of benzo[d]Imidazo[2,1-b]Thiazole derivatives bearing 1,3,4-Oxadiazole moiety as potential tumor suppressors","author":"Zhao","year":"2021","journal-title":"Bioorg Med Chem"},{"issue":"20","key":"10.1016\/j.bmc.2025.118392_bb0485","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1021\/jm901031h","article-title":"Lycorine, the Main Phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in Cancer cells that display resistance to Proapoptotic stimuli: An investigation of structure\u2212activity relationship and mechanistic insight","volume":"52","author":"Lamoral-Theys","year":"2009","journal-title":"J Med Chem"},{"issue":"19","key":"10.1016\/j.bmc.2025.118392_bb0490","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.1021\/jm8006195","article-title":"Antitumor compounds based on a natural product consensus pharmacophore","volume":"51","author":"Lagisetti","year":"2008","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2025.118392_bb0495","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.3892\/ol.2017.5923","article-title":"Andrographolide induces apoptotic and non-apoptotic death and enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in gastric Cancer cells","volume":"13","author":"Lim","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.bmc.2025.118392_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117291","article-title":"The development of \u03b1, \u03b2-unsaturated lactam-based Andrographolide derivatives as anti-gastric Cancer agents with the ability of inhibiting the ERK\/c-Fos\/Jun pathway","volume":"286","author":"Zhang","year":"2025","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2025.118392_bb0505","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1021\/acs.jnatprod.1c00936","article-title":"Semisynthesis and non-small-cell lung Cancer cytotoxicity evaluation of Germacrane-type Sesquiterpene lactones from Elephantopus Scaber","volume":"85","author":"Ren","year":"2022","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2025.118392_bb0510","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c02334","article-title":"Design of ROS-triggered Sesquiterpene lactone SC prodrugs as TrxR1 covalent inhibitors for the treatment of non-small cell lung Cancer","author":"Ren","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118392_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbpa.2018.12.007","article-title":"Natural product derived privileged scaffolds in drug discovery","volume":"52","author":"Davison","year":"2019","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.bmc.2025.118392_bb0520","first-page":"157","article-title":"Natural product drug delivery: a special challenge? In Progress in medicinal chemistry","volume":"58","author":"Press","year":"2019","journal-title":"Elsevier"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625003335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625003335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:35:04Z","timestamp":1780403704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625003335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":104,"alternative-id":["S0968089625003335"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118392","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural-product-inspired potent anticancer congeners: chronological advancements, structure-activity relationship (SAR) studies and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118392"}}